MiR-526b-5p up-regulated the expression of SLC7A11 and GPX4 by inhibiting P53, which suppressed 5-FU-induced LPO and ferroptosis, and enhanced the survival, invasion, migration, and chemotherapy resistance of CRC cells [139]. Here, TP53 is linked to colorectal carcinoma.